Medical Oncologist
CION Cancer Clinics
Who is suitable for TACE in liver cancer? | CION Cancer Clinics
TACE is mainly for primary liver cancer that is too large or too many to remove or ablate, has not spread outside the liver, and sits in a liver that still works reasonably well. That usually means BCLC stage B with Child-Pugh A. This page explains what the team weighs, who should not have TACE, and what is offered instead. At CION Cancer Clinics, a multidisciplinary tumour board weighs your liver function and your scans before recommending any treatment.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
The short answer
Who is TACE usually offered to?
TACE is mainly for people with primary liver cancer (HCC) that is too large or too many to remove or ablate, but has not spread outside the liver or into the main portal vein, and whose liver is still working reasonably well. In staging language, that is usually BCLC stage B, the intermediate stage.
What TACE is, in one line
TACE (transarterial chemoembolisation) delivers chemotherapy straight into the artery feeding the tumour and then blocks that artery, starving the tumour of blood. It is done by an interventional radiologist through a thin tube passed from the groin or wrist. The technique itself is explained on the TACE procedure page.
Why suitability matters so much
TACE treats the tumour, but it also stresses the liver around it. In the right person it controls the cancer for a useful time. In the wrong person it can tip a struggling liver into failure. That is why the decision rests on the liver as much as on the tumour.
This page is about cancer that started in the liver. TACE for cancer that spread to the liver from elsewhere is a different decision, covered on the page about TACE for liver metastases.Three things weighed
What does the team look at before saying yes to TACE?
Every TACE decision balances the tumour, the liver and the person. A good answer on one does not make up for a poor answer on another.
The tumour
How many tumours there are, how big, and where. TACE suits disease that is confined to the liver.
Points in favour
- Several tumours, or one too large to ablate
- No spread outside the liver
- Main portal vein free of tumour
- A clear arterial blood supply on the scan
The liver
Liver function is judged with the Child-Pugh score, a grade built from bilirubin, albumin, clotting (INR), fluid in the abdomen and confusion. Child-Pugh A is the best fit. Some people in the early part of Child-Pugh B may still be considered.
The page on why Child-Pugh decides treatment explains the grades.The person
How active you are day to day, your kidney function, and other illnesses such as heart disease or diabetes. Someone who is up and about, caring for themselves, is a much safer candidate than someone largely in bed.
The goal
For most people TACE aims to control the cancer, not remove it for good. Sometimes it is used to keep a tumour in check while waiting for a transplant, or to shrink it towards surgery.
Not sure whether this applies to you?
Ask an oncologistHow it is decided
What happens before you are told TACE is right for you?
A recent contrast scan
A triple-phase CT or MRI shows the number, size and blood supply of the tumours and whether the portal vein is clear. CION arranges this through its diagnostic partners if it has not been done recently.
Blood tests
Bilirubin, albumin, INR, platelets and kidney function. These feed the Child-Pugh score and show whether the kidneys can clear the contrast dye used during TACE.
The tumour board
Medical oncologists, surgeons and the interventional radiologist review the scan together. They ask whether surgery, ablation or a transplant assessment would serve you better first.
A plain conversation
You hear why TACE is being suggested, what it aims to do, and what the alternatives are. CION coordinates the procedure through NABH-accredited partner hospitals, and your team will tell you where it takes place.
Side by side
When is TACE chosen over other treatments?
If the situation is
The team usually looks at
One small tumour in a liver that works well
Surgery or ablation first, which aim at curative treatment
Several tumours, liver only, liver working well
TACE, the classic fit
Tumour in the main portal vein or spread outside the liver
Systemic treatment such as immunotherapy, sometimes radiation or TARE
Tumour widespread through both sides of the liver
Systemic treatment, as TACE would stress too much liver
Severe cirrhosis with jaundice or uncontrolled fluid
Liver-protecting care, and a transplant assessment where it fits
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Who it does not suit
Who should not have TACE?
TACE is not safe for everyone with a liver tumour. It is usually ruled out if the liver is already failing, shown by deepening jaundice, fluid in the abdomen that keeps coming back, or episodes of confusion. It is also avoided when tumour has blocked the main portal vein, because the liver then depends on the artery that TACE would close.
Other reasons the team may say no
Cancer that has spread to the lungs, bones or lymph nodes needs treatment that reaches the whole body. Poor kidney function, an uncontrolled infection, or a blocked bile duct that has not been drained can make the procedure unsafe. Someone who is mostly confined to bed is unlikely to benefit. The page on when TACE is not safe covers these in more detail.
When it stops being the right choice
Some people have TACE more than once. If the tumour keeps growing despite repeated sessions, or the liver weakens after each one, the team will usually move to systemic treatment such as immunotherapy for liver cancer. Being told TACE is no longer suitable is not the end of treatment.
Being straight with you
What can this page not tell you?
It cannot tell you whether you are suitable. The rules above are general, and real decisions sit in grey areas: a liver that is borderline, a tumour close to a major vessel, or a person whose fitness is hard to judge. Those calls need your scan, your blood results and someone who has examined you.
When the evidence is thin
Trials of TACE were done mostly in people with good liver function. For people in the grey zone, such as Child-Pugh B, the evidence is weaker, and specialists sometimes disagree. It is fair to ask your team how confident they are, and why.
Asking for a second opinion
Families often travel to Hyderabad from the districts and want to be sure before a procedure. Asking for a second opinion on whether TACE is the right step, or whether surgery, ablation or a tablet would suit better, is reasonable and will not offend a good team. Bring the scan images on a disc or link, not only the printed report.
Write down your questions before the appointment. The list on questions to ask before your first TACE is a good place to start.Questions we are asked
Common questions about who can have TACE
Can TACE be done if I have cirrhosis?
Yes. Most people who have TACE have cirrhosis. What matters is how well the liver still works. People with Child-Pugh A are the best fit, and some with early Child-Pugh B are considered. A liver that is already failing is usually not safe to treat this way.
Is TACE only for BCLC stage B?
Stage B is where TACE fits most often. It is also used in early-stage cancer when surgery or ablation is not possible, and sometimes to control a tumour while someone waits for a transplant. It is rarely the main treatment once cancer has spread outside the liver.
Can elderly patients have TACE?
Age alone does not rule it out. An older person who is active, with a liver that works well and healthy kidneys, can be a good candidate. The team looks at overall fitness and other illnesses, not the number on the birth certificate.
Does a high AFP mean TACE will not work?
No. AFP is a blood marker the team watches, and a very high level can suggest more aggressive disease. It does not on its own rule TACE out. It helps the team track how the tumour responds after each session.
What if the portal vein is involved?
It depends on which branch. A small branch may still allow careful TACE in selected people. Tumour in the main portal vein usually rules it out, and systemic treatment, radiation or TARE are considered instead. Your scan report will describe which vessels are involved.
Can TACE be combined with tablets or immunotherapy?
Combinations are being studied and are sometimes used. The evidence is still developing, and the decision is made case by case at the tumour board. The page on TACE combined with systemic treatment explains where things stand.
Is TACE covered by Aarogyasri or insurance?
Government schemes and many insurance policies do cover liver-directed procedures, but the details change and must be checked at the time. Ask for a written, itemised estimate, and ask the team to help with the scheme paperwork before the date is fixed.
How do I find out if I am suitable?
Bring your latest contrast scan, recent blood reports and a list of your medicines to a consultation. The tumour board will review them and tell you whether TACE fits, or what would suit you better. Call the CION helpline to arrange this.
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Embolization Therapy for Liver Cancer
- American Cancer Society — Treatment of Liver Cancer, by Stage
- National Cancer Institute — Liver Cancer Treatment
- Cancer Research UK — Treatment for liver cancer
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Have you been told TACE might be an option?
Send us the latest scan and blood reports, and the tumour board will tell you whether TACE fits or what would suit you better. One helpline serves every CION centre.